Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Drug-induced vasculitis

Drug-induced vasculitis April 2013 No. 279 Founded in 1966 by Professor D M Davies, FRCP, FRCP Ed ISSN 0044–6394 vasculopathy’, ‘induced vasculitis’ and Drug-induced vasculitis ‘induced vasculopathy’, published in the past 10 years in all languages, with abstracts a, b, c available in English. Reports already Lu´cia Taborda , Beatriz Amaral & David Isenberg a included in systematic case reviews were Internal Medicine Department, Hospital Nossa Senhora do Rosa´rio, Centro Hospitalar b excluded. The World Health Organization- Barreiro-Montijo, Barreiro, Internal Medicine Department, Hospital de Santa Maria, c Uppsala Monitoring Centre (WHO-UMC) Centro Hospitalar Lisboa Norte, Lisboa, Portugal and University College London system and the Naranjo Adverse Drug Reac- Hospital, London, UK tions Probability Scale have been used for Correspondence to Lu´cia Taborda, Internal Medicine Department, Hospital Nossa standardized case causality assessment. Senhora do Rosario, Centro Hospitalar Barreiro-Montijo, Barreiro, Portugal. E-mail: lucia.taborda@gmail.com Lucia Taborda, Beatriz Amaral contributed equally to the writing of the article. Discussion Definition Drug-induced vasculitis could theoretically Summary be defined as an inflammatory vasculopathy Drug-induced vasculitis is an inflammatory vasculopathy associated with drugs of in which a specific drug is established as the 2,3 almost every class and accounting for approximately 3% of the vasculitides. causal agent, other causes http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Adverse Drug Reaction Bulletin Wolters Kluwer Health

Drug-induced vasculitis

Isenberg, David
Adverse Drug Reaction Bulletin , Volume Publish Ahead of Print – Mar 1, 2013
Download PDF
4 pages

Loading next page...
 
/lp/wolters-kluwer-health/drug-induced-vasculitis-HE1a7ge1bI

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
ISSN
0044-6394
eISSN
2159-7774
DOI
10.1097/FAD.0b013e32836106df
Publisher site
See Article on Publisher Site

Abstract

April 2013 No. 279 Founded in 1966 by Professor D M Davies, FRCP, FRCP Ed ISSN 0044–6394 vasculopathy’, ‘induced vasculitis’ and Drug-induced vasculitis ‘induced vasculopathy’, published in the past 10 years in all languages, with abstracts a, b, c available in English. Reports already Lu´cia Taborda , Beatriz Amaral & David Isenberg a included in systematic case reviews were Internal Medicine Department, Hospital Nossa Senhora do Rosa´rio, Centro Hospitalar b excluded. The World Health Organization- Barreiro-Montijo, Barreiro, Internal Medicine Department, Hospital de Santa Maria, c Uppsala Monitoring Centre (WHO-UMC) Centro Hospitalar Lisboa Norte, Lisboa, Portugal and University College London system and the Naranjo Adverse Drug Reac- Hospital, London, UK tions Probability Scale have been used for Correspondence to Lu´cia Taborda, Internal Medicine Department, Hospital Nossa standardized case causality assessment. Senhora do Rosario, Centro Hospitalar Barreiro-Montijo, Barreiro, Portugal. E-mail: lucia.taborda@gmail.com Lucia Taborda, Beatriz Amaral contributed equally to the writing of the article. Discussion Definition Drug-induced vasculitis could theoretically Summary be defined as an inflammatory vasculopathy Drug-induced vasculitis is an inflammatory vasculopathy associated with drugs of in which a specific drug is established as the 2,3 almost every class and accounting for approximately 3% of the vasculitides. causal agent, other causes

Journal

Adverse Drug Reaction Bulletin – Wolters Kluwer Health

Published: Mar 1, 2013

There are no references for this article.